Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.13B 1.01B 934M 846M 1.58B 107B 1.61B 11.24B 4.45B 56.2B 4.24B 4.15B 178B P/E 2026 *
-23.7x
P/E 2027 * -29.2x
Enterprise Value 1.22B 1.09B 1.01B 916M 1.71B 116B 1.74B 12.17B 4.82B 60.85B 4.59B 4.49B 193B EV / Sales 2026 *
5.77x
EV / Sales 2027 * 5.28x
Free-Float
45.47%
Yield 2026 *
-
Yield 2027 * -
1 day+3.55%
1 week+8.44%
Current month-1.04%
1 month-0.26%
3 months+12.13%
6 months+113.52%
Current year+133.23%
1 week 6.73
Extreme 6.73
7.62
1 month 6.33
Extreme 6.334
8.74
Current year 2.8
Extreme 2.8
9.42
1 year 2.54
Extreme 2.545
9.42
3 years 1.66
Extreme 1.665
11.56
5 years 1.66
Extreme 1.665
46.43
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Tax

Chief Executive Officer

-29,250 0.0196%
9/30/26 Tax

Chief Financial Officer

-5,465 0.0037%
9/8/26 Tax

Chief Executive Officer

-29,250 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+3.55%+8.44%+122.29%+18.81% 1.09B
+0.88%-0.34%+40.64%+73.05% 64.69B
-0.26%+6.91%+11.14%+77.36% 54.78B
+0.47%+3.52%+8.22%+100.95% 53.49B
-2.06%+2.90%+24.07%+48.36% 45.98B
-1.79%+0.19%+19.32%+123.62% 42.94B
-1.65%+0.96%+237.56%+823.66% 40.08B
-2.26%-4.14%+15.38%+45.53% 33.52B
-3.92%-12.41%+17.60%-8.19% 23.97B
+12.10%+16.60%+55.14%+46.15% 23.67B
Average +0.45%+1.98%+55.14%+134.93% 38.42B
Weighted average by Cap. -0.16%+1.64%+45.58%+149.26%

Financials

2026 *2027 *
Net sales 212M 189M 175M 159M 297M 20.15B 302M 2.11B 834M 10.54B 795M 778M 33.37B 225M 201M 186M 168M 315M 21.4B 320M 2.24B 886M 11.19B 844M 826M 35.43B
Net income -55.79M -49.89M -46.16M -41.79M -78.22M -5.31B -79.5M -555M -220M -2.78B -209M -205M -8.79B -40.65M -36.35M -33.63M -30.45M -56.98M -3.87B -57.92M -405M -160M -2.02B -153M -149M -6.4B
Net Debt 93.41M 83.53M 77.28M 69.97M 131M 8.89B 133M 930M 368M 4.65B 351M 343M 14.72B 58.85M 52.63M 48.69M 44.09M 82.51M 5.6B 83.86M 586M 232M 2.93B 221M 216M 9.27B
Projected Income Statement - Annual - Maravai LifeSciences Holdings, Inc.
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
415
Date Price Change Volume
26-10-26 US$7.580 +3.55% 1,285,127
26-10-23 US$7.320 +3.54% 1,447,717
26-10-22 US$7.070 -6.61% 3,920,308
26-10-21 US$7.570 +5.14% 1,699,963
26-10-20 US$7.200 +3.00% 2,022,517
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Maravai LifeSciences Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
7.580USD
Average target price
8.500USD
Spread / Average Target
+12.14%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Maravai LifeSciences Holdings, Inc.
  1. Stock Market
  2. Stocks
  3. MRVI Stock